GRAS approvals highlight Section 912 “nightmare”
Industry continues to urge the Food and Drug Administration to close the Section 912 loophole in the Federal Food, Drug, and Cosmetic Act (FDCA) that could allow nutrients such as omega-3s, L-arginine and baobab to be reclassified as drugs.